0 CHECKOUT

Switzerland Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3517947
  • December 2015
  • Region: Switzerland
  • 71 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Novartis
  • Roche
  • MORE

Roche's restructuring efforts within its manufacturing network are indicative of deep pipeline shifts. Tailored manufacturing capability will support the company's established biosimilar defence strategy as it prepares itself for erosion of key product revenues to begin in 2018. As part of an industry-wide trend, we expect to see further traditional small-molecule plants being decommissioned and investment being put into increasing in-house biologics capabilities.

Headline Expenditure Projections
- Pharmaceuticals: CHF7.06bn (USD7.71bn) in 2014 to CHF7.07bn (USD7.27bn) in 2015; +0.10% in local currency terms and -5.8% in US dollar terms. Forecast stayed flat compared to last quarter.

- Healthcare: CHF70.49bn (USD77.02bn) in 2014 to CHF71.88bn (USD73.89bn) in 2015; +2.0% growth in local currency terms and -4.1% in US dollar terms. Forecast revised slightly downwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Novartis
  • Roche
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Switzerland 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019)

OTC Medicine Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Switzerland 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Switzerland 2013-2019)

Industry Risk/Reward Index

Western Europe Risk/Reward Index

Switzerland Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector
Table: 2013 & 2014: Health Insurance Premiums
Table: Healthcare Resources (Switzerland 2009-2014)
Table: Healthcare Personnel (Switzerland 2009-2014)
Table: Healthcare Activity (Switzerland 2009-2014)

Research And Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Table: Multinational Market Activity

Drugmakers

Retail

Company Profile

Novartis

Roche

GlaxoSmithKline

Demographic Forecast
Table: Population Headline Indicators (Switzerland 1990-2025)
Table: Key Population Ratios (Switzerland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Switzerland 1990-2025)
Table: Population By Age Group (Switzerland 1990-2025)
Table: Population By Age Group % (Switzerland 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Novartis
Roche
GlaxoSmithKline

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S